DTx Pharma Promotes Bryan Laffitte, Ph.D. to Chief Scientific Officer
SAN DIEGO, January 11, 2020 PRNewswire – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers [...]
DTx Pharma to Present at the Virtual Biotech Showcase 2021
SAN DIEGO, January 4, 2020 PRNewswire – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of [...]
DTx Pharma to Present at Several Upcoming Virtual Events
SAN DIEGO, Nov. 25, 2020 PRNewswire – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers [...]
DTx Pharma Announces Appointment of Denise Bevers as Chief Operating Officer
PR Newswire, San Diego – November 9, 2020 – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the [...]
DTx Pharma to Present at the Virtual 7th Solebury Trout Fall Private Company Showcase
PR Newswire, San Diego – October 5, 2020 – DDTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the [...]
DTx Pharma to Present at the Chardan Virtual 4th Annual Genetic Medicines Event
PR Newswire, San Diego – September 28, 2020 – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the [...]
DTx Pharma Receives New Funding Grant to Advance RNA-based Therapeutic Programs for Charcot-Marie Tooth (CMT)
-CMT is a genetic rare disease driven by the duplication of the PMP22 gene- PR Newswire, San Diego – September 21, 2020 – DTx Pharma, [...]
DTx Pharma Announces Presentations at Several Upcoming Virtual Medical Meetings
DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today that the company will [...]
DTx Pharma Announces Appointment of Bryan Laffitte, Ph.D. as Vice President, Biology
DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today the appointment of [...]
DTx Pharma Expands Footprint in San Diego with New Office and Lab Space
SAN DIEGO, May 20, 2020 /PRNewswire/ -- DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers [...]